Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/1999
11/30/1999US5994096 Regulator
11/30/1999US5994095 MTS2 gene
11/30/1999US5994094 A bone morphogenetic protein; treatment of osteoporosis, prevent transplant rejection; wound healing agents; regeneration of bones, cartilage, connective tissue, skin, mucous membranes, epithelium and teeth
11/30/1999US5994054 Creating an expression library, transfecting cells with a dna molecule which contains a long terminal repeat promoter sequence of human immunodeficiency virus adjacent to a reporter molecule, measuring viricide activity
11/30/1999US5993844 Telopeptide collagen; elastin, wherein elastin is less than 10% of the total composition based on dry weight; and, non-collagenous and non-elastinous components wherein said components are less than 5% of the total composition based on
11/30/1999US5993827 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
11/30/1999US5993824 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
11/30/1999US5993818 Use of autoantibodies for tumor therapy and prophylaxis
11/30/1999US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999US5993808 Chitinase, DNA coding therefor and plants containing same
11/30/1999US5993804 Pharmaceutically acceptable fixed-dried human blood platelets
11/30/1999CA2154178C Plants resistant to infection by plrv
11/30/1999CA2128250C Insecticidally effective peptides
11/30/1999CA2024607C Recombinant dna method and host cells
11/30/1999CA1340833C Activated killer monocytes: tumoricidal activity and method of monitoring same
11/30/1999CA1340832C Recombinant cmv neutralizing proteins
11/30/1999CA1340831C Ribozymes
11/25/1999WO1999060153A2 Novel g-protein coupled receptor
11/25/1999WO1999060146A1 Adeno-associated virus vectors and uses thereof
11/25/1999WO1999060144A1 Methods and compositions for producing viral particles
11/25/1999WO1999060143A1 Amphotropic retrovirus packaging cell line, process for its production and use thereof
11/25/1999WO1999060136A1 Methods for producing polypeptides in filamentous fungal mutant cells
11/25/1999WO1999060135A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases
11/25/1999WO1999060132A1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/25/1999WO1999060131A2 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
11/25/1999WO1999060127A2 Il-17 homologous polypeptides and therapeutic uses thereof
11/25/1999WO1999060105A1 Flat sheet cell encapsulation device
11/25/1999WO1999060099A1 Amino acid modified polypeptides
11/25/1999WO1999060097A1 clpX OF $i(STREPTOCOCCUS PNEUMONIAE)
11/25/1999WO1999060024A1 Methods for amyloid removal using anti-amyloid antibodies
11/25/1999WO1999060020A1 Secreted proteins and polynucleotides encoding them
11/25/1999WO1999060019A1 HUMAN EDG3sb GENE
11/25/1999WO1999060017A2 Human tumour-derived polypeptide hormone phosphatonin
11/25/1999WO1999060008A1 Cytosine deaminase gene
11/25/1999WO1999059629A1 Humanized antibodies that recognize verotoxin ii and cell line producing same
11/25/1999WO1999059620A1 Angiostatin receptor
11/25/1999WO1999059619A1 Acrp30r1: a homolog of acrp30 (30 kd adipocyte complement-related protein)
11/25/1999WO1999059618A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein)
11/25/1999WO1999059611A1 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
11/25/1999WO1999059578A1 Triterpene compositions and methods for use thereof
11/25/1999WO1999059506A1 Corporal tissue penile reconstruction
11/25/1999WO1999059398A2 Regeneration system for grape and uses thereof
11/25/1999WO1999050301A3 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
11/25/1999WO1999049014A9 Localization and propagation of neural and neuronal progenitor cells
11/25/1999WO1999045103A3 Human spinal cord cell lines and methods of use therefor
11/25/1999WO1999043832A3 Human proteinase molecules
11/25/1999WO1999043808A8 Human c-maf compositions and methods of use thereof
11/25/1999WO1999043787A3 A living chimeric skin replacement
11/25/1999WO1999040924A3 Treatment of neurodegeneration
11/25/1999WO1999040199A3 A novel fungal protein critical for expression of fungal proteins
11/25/1999WO1999040180A9 Expanded and genetically modified populations of human hematopoietic stem cells
11/25/1999WO1999038976A3 Human growth factor homologs
11/25/1999WO1999031969A3 Transgenic animal model for degenerative diseases of cartilage
11/25/1999WO1999005527A3 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
11/25/1999DE19824306A1 Fibrin glue useful in tissue engineering, biotechnology and surgery
11/25/1999DE19806803A1 Transporter für Saccharid-gekoppelte Zytostatika in Tumorzellen Transportation for saccharide-linked cytotoxic agents in tumor cells
11/25/1999CA2333144A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases
11/25/1999CA2332639A1 Methods and compositions for producing viral particles
11/25/1999CA2332507A1 Angiostatin receptor
11/25/1999CA2330471A1 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
11/25/1999CA2329153A1 Novel g-protein coupled receptor
11/25/1999CA2329139A1 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
11/25/1999CA2328596A1 Cytosine deaminase gene
11/25/1999CA2328496A1 Il-17 homologous polypeptides and therapeutic uses thereof
11/25/1999CA2328489A1 Secreted proteins and polynucleotides encoding them
11/25/1999CA2325600A1 Methods for amyloid removal using anti-amyloid antibodies
11/25/1999CA2296362A1 Regeneration system for grape and uses thereof
11/24/1999EP0959131A2 Method for cloning and producing the AgeI restriction endonuclease in E. coli
11/24/1999EP0958371A2 Cytopathic viruses for therapy and prophylaxis of neoplasia
11/24/1999EP0958366A1 Human chemokine beta-13
11/24/1999EP0958365A1 Granulocyte chemotactic protein 2 variant
11/24/1999EP0958363A1 Human regulator of g-protein signaling - (hrgs)
11/24/1999EP0958361A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders
11/24/1999EP0958359A1 Protein inhibitor of neuronal nitric oxide synthase
11/24/1999EP0958304A1 Nucleotide sequence encoding the cd33-like protein
11/24/1999EP0958046A1 Cell separation composition, kit and method
11/24/1999EP0957944A2 Bone matrix, the utilization thereof, therapeutic preparation and kit
11/24/1999EP0957903A1 Pharmaceutical compositions and methods
11/24/1999EP0957831A1 Process and device for the culture of bone replacement material
11/24/1999EP0845045A4 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors
11/24/1999EP0767841A4 Taxane production in haploid-derived cell cultures
11/24/1999CN1236394A Herbicide resistant plants
11/24/1999CN1236393A Chitinase materials and methods
11/24/1999CN1236392A Phsopholipase D and DNA sequences
11/24/1999CN1236391A Method for producing recombinants intended for use in a complete malaria antigene gp 190/MSP1
11/24/1999CN1236390A Angiogenic factor and use thereof of treating cardiovascular disease
11/23/1999US5991028 Spectral bio-imaging methods for cell classification
11/23/1999US5990395 Inbred sweet corn line W1498A
11/23/1999US5990388 Transgenic plant expressing a cloned dna encoding a vaccinia virus e3l protein at a level to complex and sequester double-stranded rna-like structure of virus/viroid; biological pest control; viricides
11/23/1999US5990383 Plant transformed with nucleotide sequence which encodes a vegetative insecticidal protein from bacillus species
11/23/1999US5990297 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
11/23/1999US5990287 Immunoglobulin which binds to surface antigen of stomach cancer cell mnk45 and colon cancer cell c-1; for diagnosis of cancer; for anticarcinogenic agents and immunotoxins
11/23/1999US5990282 Receptor protein for human B cell stimulatory factor-2
11/23/1999US5990281 Amino acid sequence of native polypeptide which interacts with hedgehog and patched signaling molecules involved in cell proliferation and differentiation; for therapy and diagnosis
11/23/1999US5990280 Factor which is heat resistant but sensitive to acidic and alkaline conditions, does not bind heparin, induced by wild type p53 expression, is not thrombospondin, molecular weight of about 100 kilodaltons; diagnosis, anticarcinogenic agents
11/23/1999US5990177 Treatment of diseases mediated by the nitric oxide/cGMP/protein kinase G pathway
11/23/1999US5989915 Using particles coated with exogenous genetic construct including marker gene, accelerating particles into cells, regenerating shoots, analyzing shoot segments for marker gene expression, regenerating high expression shoots
11/23/1999US5989908 Nucleic acid encoding ribozyme used for suppression of c-fos oncogene expression in mammalian cells exhibiting multidrug resistant phenotype; increase cell sensitivity to anticarcinogenic/antitumor agents
11/23/1999US5989907 Methods and compositions for calcium binding proteolipid encoding nucleic acids
11/23/1999US5989890 Compositions and methods for PACE 4 and 4.1 gene and polypeptides in cells